Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136981
Status:
COMPLETED
Last Update Posted:
2015-04-22
First Post:
2005-08-25
Brief Title:
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of TorcetrpibAtorvastatin to Atorvastatin Alone
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase 3 Multi-Center Double-Blind Randomized Parallel Group Carotid B-Mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy Safety and Tolerability of Fixed Combination CP-529414Atorvastatin Administered Orally Once Daily QD for 24 Months Compared With Maximally Tolerated Atorvastatin Therapy Alone in Subjects With Heterozygous Familial Hypercholesterolemia
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RADIANCE 1
Brief Summary:
The Torcetrapib project was terminated on December 2 2006 due to safety findings
To look at ultrasound images taken in the carotid arteries and to look at various lipids in the blood of people with heterozygous familial hypercholesterolemia
To look at ultrasound images taken in the carotid arteries and to look at various lipids in the blood of people with heterozygous familial hypercholesterolemia
Detailed Description:
For additional information please call 1-800-718-1021
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None